0
About the Cover
RSSRSS   Get Alerts
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

March-April 2009

| Vol. 49. No. 2

Special Feature

David P. Nau, PhD, BPharm, CPHQ
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09019

Objective  To describe methods for measuring health care quality and how these methods can be applied to the measurement of ...

[Continue Reading]
Tags: diabetes mellitus, quality of care, health care financing administration, community pharmacy services, ...
Lourdes G. Planas, PhD; Kimberly M. Crosby, PharmD, BCPS, CGP; Kimberly D. Mitchell, PharmD; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.08164

Objective  To evaluate the effect of a 9-month community pharmacy–based medication therapy management (MTM) program on quality of care in ...

[Continue Reading]
Tags: hypertension, diabetes mellitus, diabetes mellitus, type 2, blood pressure, medication therapy management ...
Elizabeth A. Flynn, PhD; N. Barker Kenneth, PhD; Bruce A. Berger, PhD; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.08130

Objective  To evaluate the dispensing accuracy and counseling provided in community chain pharmacies.

Design  Cross-sectional study.

Setting  Community chain pharmacies ...

[Continue Reading]
Tags: warfarin, counseling, drug dispensing error
Emily Beth Devine, PharmD, MBA, PhD, BCPS, FASHP; Susan Hoang, PharmD, BCPS; Albert W. Fisk, MD, MMM; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.08009

Objectives  To (1) describe the role of clinical pharmacists in providing population-based pharmaceutical care as employees of a physician group ...

[Continue Reading]
Tags: group practice, clinical pharmacists
David Fox, PharmD; L. Douglas Ried, PhD; Gary E. Klein, BPharm; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09016

Objectives  To determine a medication therapy management (MTM) service's impact on (1) Healthcare Effectiveness Data and Information Set (HEDIS) quality ...

[Continue Reading]
Tags: ldl cholesterol lipoproteins, diabetes mellitus, type 2, medication therapy management, medicare part ...
Scott V. Monte, PharmD; Erin M. Slazak, PharmD, BCPS; Nicole Paolini Albanese, PharmD; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.08160

Objective  To provide program methodology and outcomes data identifying the impact of clinical pharmacy services (CPSs) in patients with type ...

[Continue Reading]
Tags: diabetes mellitus, diabetes mellitus, type 2, primary health care, economics, treatment outcome, ...
Kristy L. Brittain, PharmD; Catherine H. Kuhn, PharmD
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.08161

Background  Pay-for-performance (P4P) models are being adopted by many health care payers, including Medicare, for payment of physician services. To ...

[Continue Reading]
Tags: diabetes mellitus, diabetes mellitus, type 2, community pharmacy services
Donna Pillittere-Dugan, MS; David P. Nau, PhD, BPharm, CPHQ; Kimberly McDonough, PharmD; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09012

Objective  To report on the status of the pilot work of PQA, a pharmacy quality alliance, to develop and test ...

[Continue Reading]
Tags: pharmaceutical services, pharmacy quality alliance
Rick W. Dettloff, PharmD, BCPS; Jacqueline A. Morse, PharmD, BCPS
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09002

Objective  To integrate the resources from a local statewide managed care organization (MCO) and a supermarket pharmacy chain to conduct ...

[Continue Reading]
Tags: cardiovascular diseases, cardiovascular disease risk factors, community pharmacy services, managed care organizations ...
L. Douglas Ried, PhD; Babette Brumback, PhD; Michael A. Bengtson, MD; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.08151

Objectives  To compare (1) blood glucose and glycosylated hemoglobin (A1C) laboratory results and (2) longitudinal trends in blood glucose levels ...

[Continue Reading]
Tags: glucose, schizophrenia, veterans, blood glucose, olanzapine, atypical antipsychotic

Reviews

Frank Romanelli, PharmD, MPH, BCPS; Kelly M. Smith, PharmD, BCPS, FASHP
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.08091

Objective  To describe the epidemiology, patient presentation, and clinical management associated with dextromethorphan (DM) abuse.

Data sources  PubMed/Medline search using ...

[Continue Reading]
Tags: common cold, cough, dextromethorphan, drugs, non-prescription, ingestion, anticoagulation clinic, workflow
Lindsey P. Koliscak; Eugene H. Makela, PharmD, BCPP
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.08083

Objective  To review available information in the literature about akathisia (inner restlessness) caused by the selective serotonin reuptake inhibitors (SSRIs).

... [Continue Reading]
Tags: serotonin, selective serotonin re-uptake inhibitors, akathisia

Tools for Advancing Pharmacy Practice

Michael D. Hogue, PharmD; Randy McDonough, PharmD, BCGPS; Marialice Bennett, BPharm; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.08038

Objectives  To explain the purpose of superbills, suggest strategies for incorporating superbills into pharmacy practice, and propose a model superbill ...

[Continue Reading]
Tags: ambulatory care services, community pharmacy services, medication therapy management

Features

J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09512

The following are abstracts of original research being presented at APhA2009, April 3–6, 2009, San Antonio, TX. Inquiries specific to ...

[Continue Reading]
Tags: smoking, pharmacotherapy, diabetes mellitus, diabetes mellitus, type 2, smoking cessation, attitude, community ...

Departments

J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09511
Landau et al. Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States. Jan/Feb 2009, page ... [Continue Reading]
Tags: contraceptive methods, attitude, pharmacy-access drug products

Association Report

Marialice Bennett, BPharm, FAPhA; L. Douglas Ried, PhD; Brent N. Reed; et al.
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09506
During 2008–2009, members of the APhA Academy of Pharmacy Practice & Management (APhA–APPM) made important contributions to promoting and supporting the role ... [Continue Reading]
Tags: advisory committees, awards and prizes, face, students, pharmacy, medication therapy management, advocacy ...

Viewpoint

L. Douglas Ried, PhD
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09513
What is quality? According to Robert Pirsig+1 in his novel Zen and the Art of Motorcycle Maintenance, quality is indefinite because everyone ... [Continue Reading]
Tags: aspirations (psychology), pulmonary aspiration
Carmen Y. Kelly, PharmD; Carolyn M. Clancy, MD
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.08171
Improving quality of care and enhancing patient safety are twin goals of the Agency for Healthcare Research and Quality (AHRQ). Today, pharmacists ... [Continue Reading]
Tags: medication errors, pharmaceutical services, patient safety, health literacy
Michael T. Rupp, PhD, BPharm
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09010
In this issue of the Journal of the American Pharmacists Association, researchers from Auburn University+1 report their study of dispensing errors in ... [Continue Reading]
Tags: community pharmacy services, counseling
Lawrence M. Brown, PharmD, PhD
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09030
The issue of pharmacy quality measurement is one of extreme importance given the current environment of medication therapy management (MTM) services, evidence-based ... [Continue Reading]
Tags: client satisfaction, quality of care, cost effectiveness, evidence-based medicine, health care reform, ...

Heroes of Pharmacy

Dennis B. Worthen, PhD
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09507
James Hartley Beal, the first editor of the Journal of the American Pharmaceutical Association and long-time chair of the board of trustees ... [Continue Reading]
Tags: libraries, plants

New Drugs

Daniel A. Hussar, PhD
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09509
Fibromyalgia is one of the most common types of chronic widespread muscle pain, affecting an estimated 3 to 6 million Americans. Most ... [Continue Reading]
Tags: milnacipran, silodosin, fesoterodine

Science Snippets

L. Douglas Ried, PhD
J Am Pharm Assoc.    doi: 10.1331/JAPhA.2009.09510
Falls are associated with medications with substantial central nervous system (CNS) complications among older patients. Joseph T Hanlon, PharmD, University of Pittsburgh, ... [Continue Reading]
Tags: warfarin, pharmacogenetics, recurrent falls
J Am Pharm Assoc.   
Tags: medication errors, united states pharmacopeia
Abstract
close X
Advertisement